EICHORCondition: Osteoarthritis · Sponsor: Grünenthal GmbH
A double-blind, randomized, placebo-controlled, parallel-group, multi-site, clinical trial to confirm the efficacy and safety of single injection of RTX-GRT7039 versus placebo in patients who have pain associated with osteoarthritis of the knee despite standard of care.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Achieve Clinical Research, LLC | Birmingham, Alabama, United States | — |
| Arizona Arthritis and Rheumatology Associates (AARA) P.C | Glendale, Arizona, United States | — |
| Elite Clinical Studies, LLC | Phoenix, Arizona, United States | — |
| Noble Clinical Research | Tucson, Arizona, United States | — |
| Tucson Orthopaedic Research Center | Tucson, Arizona, United States | — |
| Orange County Research Institute | Anaheim, California, United States | — |
| Core Health Care Group | Cerritos, California, United States | — |
| Acclaim Clinical Research, Inc. | San Diego, California, United States | — |
| Dr. Hans Richard Barthel, MD Office Of | Santa Barbara, California, United States | — |
| Medvin Clinical Research | Thousand Oaks, California, United States | — |
| Westlake Medical Research | Thousand Oaks, California, United States | — |
| Allied Biomedical Research Institute | Miami, Florida, United States | — |
+ 69 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05449132